EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:749493 - efalizumab
| ChEBI ID | CHEBI:749493 |
| ChEBI Name | efalizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| efalizumab (CHEBI:749493) has role antipsoriatic (CHEBI:50748) |
| efalizumab (CHEBI:749493) has role antirheumatic drug (CHEBI:35842) |
| efalizumab (CHEBI:749493) has role hypoglycemic agent (CHEBI:35526) |
| efalizumab (CHEBI:749493) has role ophthalmology drug (CHEBI:66981) |
| efalizumab (CHEBI:749493) has role renoprotective agent (CHEBI:231911) |
| efalizumab (CHEBI:749493) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| ANTI-CD11A | ChEMBL |
| Efalizumab | ChEMBL |
| HU-1124 | ChEMBL |
| HU1124 | ChEMBL |
| Brand Name | Source |
|---|---|
| Raptiva | ChEMBL |